Basel Medical Group Ltd (BMGL)

Basel Medical Group will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$4.00 - $5.00

Shares Offered

2,500,000

Deal Size

$11.25M

Basel Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	9.75	9.7	10.66
Revenue Growth (YoY)	-	-8.98%	-
Cost of Revenue	-	2.34	2.18
Gross Profit	7.47	7.36	8.48
Selling, General & Admin	-	3.27	4.04
Other Operating Expenses	0	1.97	2.05
Operating Expenses	-	5.23	6.09
Operating Income	3.47	2.13	2.39
Interest Expense / Income	-	0.24	0.32
Other Expense / Income	0.97	-0.24	-0.32
Pretax Income	2.51	2.13	2.39
Income Tax	-	0.35	0.41
Net Income	2.51	1.78	1.98
Net Income Growth	-	-9.84%	-
Free Cash Flow	1.66	2.59	2.7
Gross Margin	76.57%	75.91%	79.56%
Operating Margin	35.60%	21.97%	22.39%
Profit Margin	25.70%	18.38%	18.56%
Free Cash Flow Margin	17.07%	26.74%	25.37%
Effective Tax Rate	-	16.34%	17.12%
EBITDA	-	2.93	3.28
EBITDA Margin	-	30.17%	30.80%
Depreciation & Amortization	-	0.56	0.58
EBIT	-	2.37	2.71
EBIT Margin	-	24.43%	25.40%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).